Behavioral Determinants of Cannabinoid Self-Administration in Old World Monkeys

Neuropsychopharmacology

Volumn 42, Issue 7, 2017, Pages 1522-1530

  John, William S ^a   Martin, Thomas J ^a   Nader, Michael A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABINOID RECEPTOR AGONIST; COCAINE; SODIUM CHLORIDE; 3-(2-HYDROXY-4-(1,1-DIMETHYLHEPTYL)PHENYL)-4-(3-HYDROXYPROPYL)CYCLOHEXANOL; CANNABINOID RECEPTOR; CYCLOHEXANOL DERIVATIVE; DRONABINOL;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DRUG DOSE; DRUG SELF ADMINISTRATION; FOOD; FOOD MAINTAINED RESPONDING; MACACA FASCICULARIS; MALE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; RHESUS MONKEY; ANIMAL; CERCOPITHECIDAE; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; REACTION TIME;

ANIMALS; CANNABINOID RECEPTOR AGONISTS; CANNABINOIDS; CERCOPITHECIDAE; CYCLOHEXANOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRONABINOL; MACACA FASCICULARIS; MACACA MULATTA; MALE; REACTION TIME; RECEPTORS, CANNABINOID; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION;

EID: 85011294172     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2017.2     Document Type: Article

References (44)

1. Azofeifa A, Mattson ME, Schauer G, McAfee T, Grant A, Lyerla R (2016). National estimates of marijuana use and related indicators - National Survey on Drug Use and Health, United States, 2002-2014. MMWR Surveill Summ 65: 1-25.
2. Beardsley PM, Balster RL, Harris LS (1986). Dependence on tetrahydrocannabinol in rhesus monkeys. J Pharmacol Exp Ther 239: 311-319.
3. Carney JM, Uwaydah IM, Balster RL (1977). Evaluation of a suspension system for intravenous self-administration of water insoluble substances in the rhesus monkey. Pharmacol Biochem Behav 7: 357-364.
4. 9-tetrahydrocannabinol. Biochem Pharmacol 22: 399-405.
5. Fan F, Compton DR, Ward S, Melvin L, Martin BR (1994). Development of cross- tolerance between delta 9-tetrahydrocan-nabinol, CP 55,940 and WIN 55,212. J Pharmacol Exp Ther 271: 1383-1390.
6. Fattore L, Cossu G, Martellotta CM, Fratta W (2001). Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats. Psychopharmacology 156: 410-416.
7. Ghozland S, Mathews H, Simonin F, Filliol D, Kieffer BL, Maldonado R (2002). Motivational effects of cannabinoids are mediated by - and k-opioid receptors. J Neurosci 22: 1146-1154.
8. Gifford AN, Bruneus M, Lin S, Goutopoulos A, Makriyannis A, Volkow ND et al (1999). Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374). Eur J Pharmacol 383: 9-14.
9. 9-tetrahydrocannabinol in rhesus monkeys with different patterns of exposure. Drug Alcohol Depend 139: 1-8.
10. Haertzen CA, Kocher TR, Miyasato K (1983). Reinforcements from the first drug experience can predict later drug habits and/or addiction: results with coffee, cigarettes, alcohol, barbiturates, minor and major tranquilizers, stimulants, marijuana, hallucinogens, heroin, opiates and cocaine. Drug Alcohol Depend 11: 147-165.
11. 9-tetrahydrocannabinol in monkeys. Psychopharmacologia 37: 23-29.
12. Hunt CA, Jones RT (1980). Tolerance and disposition of tetra-hydrocannabinol in man. J Pharmacol Exp Ther 215: 35-44.
13. John WS, Banala AK, Newman AH, Nader MA (2015a). Effects of buspirone and the dopamine D3 receptor compound PG619 on cocaine and methamphetamine self-administration in rhesus monkeys using a food-drug choice paradigm. Psychopharmacology (Berl) 232: 1279-1289.
14. John WS, Newman AH, Nader MA (2015b). Differential effects of the dopamine D3 receptor antagonist PG01037 on cocaine and methamphetamine self-administration in rhesus monkeys. Neuropharmacology 92: 34-43.
15. Justinova Z, Mascia P, Wu H-Q, Secci ME, Redhi GH, Panlilio L et al (2013). Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid. Nat Neurosci 16: 1652-1661.
16. Justinova Z, Munzar P, Panlilio LV, Yasar S, Redhi GH, Tanda G et al (2008). Blockade of THC-seeking behavior and relapse in monkeys by the cannabinoid CB(1)-receptor antagonist rimona-bant. Neuropsychopharmacology 33: 2870-2877.
17. Justinova Z, Tanda G, Redhi GH, Goldberg SR (2003). Self-administration of delta(9)-tetrahydrocannabinol (THC) by drug naive squirrel monkeys. Psychopharmacology 169: 135-140.
18. Kangas BD, Leonard MZ, Shukla VG, Alapafuja SO, Nikas SP, Makriyannis A et al (2016). Comparisons of A -tetrahydrocannabinol and anandamide on a battery of cognition-related behavior in nonhuman primates. J Pharmacol Exp Ther 357: 125-133.
19. Kaymakcalan S (1972). Physiology and psychological dependence on THC in rhesus monkeys. In: Paton WDM, Crown J(eds). Cannabis and its Derivatives. Oxford University Press: London. pp 142-149.
20. Kaymakcalan S (1973). Tolerance to and dependence on cannabis. Bull Narc 25: 39-47.
21. Kirk JM, De Wit H (1999). Responses to oral delta9-tetrahydrocannabinol in frequent and infrequent marijuanausers. Pharmacol Biochem Behav 63: 137-142.
22. Lefever TW, Marusich JA, Antonazzo KR, Wiley JL (2014). Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model. Pharmacol Biochem Behav 118: 30-35.
23. Leite JR, Carlini EA (1974). Failure to obtain "cannabis directed behavior" and abstinence syndrome in rats chronically treated with cannabis sativa extracts. Psychopharmacologia 36: 133-145.
24. Lepore M, Vorel SR, Lowinson J, Gardner EL (1995). Conditioned place preference induced by D9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward. Life Sci 56: 2073-2080.
25. Li J-X, Koek W, France CP (2012). Interactions between A(9)-tetrahydrocannabinol and heroin: self-administration in rhesus monkeys. Behav Pharmacol 23: 754-761.
26. Lindgren JE, Ohlsson A, Agurell S, Hollister L, Gillespie H (1981). Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis. Psychopharmacology 74: 208-212.
27. Mansbach RS, Nicholson KL, Martin BR, Balster RL (1994). Failure of A -tetrahydrocannabinol and CP 55,940 to maintain intravenous self administration under a fixed-interval schedule in rhesus monkeys. Behav Pharmacol 5: 219-225.
28. Martellotta MC, Cossu G, Fattore L, Gessa GL, Fratta W (1998). Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice. Neuroscience 85: 327-330.
29. Martin BR, Dewey WL, Harris LS, Beckner JS (1976). H-A(9)-tetrahydrocannabinol tissue and subcellular distribution in the central nervous system and tissue distribution in peripheral organs of tolerant and nontolerant dogs. J Pharmacol Exp Ther 196: 128-144.
30. McMahon LR (2011). Chronic delta9-tetrahydrocannabinol treatment in rhesus monkeys: differential tolerance and cross-tolerance among cannabinoids. Br J Pharmacol 162: 1060-1073.
31. McMillan DE, Dewey WL, Turk RF, Harris LS, McNeil JH (1973). Blood levels of 3H-D9-tetrahydrocannabinol and its metabolites in tolerant and nontolerant pigeons. Biochem Pharmacol 22: 383-397.
32. Nader MA, Lile JA, John WS, Czoty PW (2015). Nonhuman primate models of abuse liability. In Weinbauer GF, Vogel F (eds). "Primate Biologics Research at a Crossroads". Waxmann Publishing Co: Muenster, Germany. pp 37-59.
33. 9-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice. Behav Pharmacol 23: 802-805.
34. Perez-Reyes M, White WR, McDonald SA, Hicks RE, Jeffcoat AR, Cook CE (1991). The pharmacologic effects of daily marijuana smoking in humans. Pharmacol Biochem Behav 40: 691-694.
35. Pickens R, Thompson T, Muchow DC. Cannabis and phencyclidine self-administered by animals (1973). Goldfarb L, Hoffmeister F (eds). Psychic dependence [Bayer-Symposium IV]. Springer: Berlin Heidelberg New York. pp 78-86.
36. Rodriguez JS, McMahon LR (2014). JWH-018 in rhesus monkeys: differential antagonism of discriminative stimulus, rate-decreasing, and hypothermic effects. Eur J Pharmacol 740: 151-159.
37. SAMHSA (2014). Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug Use and Health: Overview of findings. NSDUH series H-48, HHS Publication No. (SMA) 14-4863. Substance Abuse and Mental Health Services Administration: Rockville, MD.
38. 9-tetrahydrocannabinol exposure alters WIN55,212-2 self-administration in adult rats. Neuropsychophar-macology 41: 1416-1426.
39. Siemens AJ, Kalant H (1974). Metabolism of delta1-tetrahyd-rocannabinol by rats tolerant to cannabis. Can J Physiol Pharmacol 52: 1154-11566.
40. 9-THC withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs. J Pharmacol Exp Ther 334: 347-356.
41. Tanda G, Munzar P, Goldberg SR (2000). Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat Neurosci 3: 1073-1074.
42. Thomas H (1996). A community survey of adverse effects of cannabis use. Drug Alcohol Depend 42: 201-207.
43. 9-tetrahydrocannabinol in mice. Psychopharma-cology 147: 436-438.
44. Van Ree JM, Slangen JL, de Wied D (1978). Intravenous self-administration of drugs in rats. J Pharmacol Exp Ther 204: 547-557.